Innovation in Vision

The Company

The cornerstone of AdOM, Advanced Optical Technologies Ltd focuses on two areas: state-of-the-art optical imaging capabilities and leading ophthalmology clinical and research skills. AdOM utilizes its team’s vast knowledge in thin-film optical imaging technologies to master the spectral imaging domain for the service of clinical ophthalmology. The company is currently focused on the commercialization of our state-of-the-art Tear Film Imaging (TFI) device which measures clinically relevant parameters of the tear film dynamics.

More than 30 different patent applications have been filed for the AdOM technology, of which twenty-one (21) were granted both in Israel, the US, and the EU. This cutting-edge technology has been published by several peer-reviewed scientific journals.

Vision

To provide superior ophthalmic assessment based on state-of-the-art hyperspectral optical technologies

Mission

To improve management of ophthalmic diseases by utilizing state of the art imaging diagnostic technology.

Mission

To improve management of ophthalmic diseases by utilizing state of the art imaging diagnostic technology.

Key Personnel

Dovi Frumovich

CEO

Stan Miele, MBA

CEO AdOM Americas Corp.

John Abrams, MD

Chairman of the Board

Galia Goldenberg, LLB (HONS)

Business Development & Marketing Manager

Raanan Gefen, MBA

CTO

Edan Kenig, MS

COO

Scientific Advisory Board

John D. Sheppard, M.D., M.M.Sc.

President of Virginia Eye Consultants

Dr. Fani Segev, MD

Cornea Specialist, Assuta Hospital

Prof Alon Harris MS, Ph.D, FARVO

Prof. of Ophthalmology & AI, Mount Sinai, NY

Prof. Leejee H. Suh, MD

Director, Cornea Service, Columbia University, NY

Dr. Anat Galor, MD

Cornea Specialist, Bascom Palmer Eye Institute, FL

Prof. Guy Kleinmann

Chairman Dept. of Ophthalmology
Sheba Hospital

Barbara M. Wirostko, MD, FARVO

Moran Eye Center

Prof. Ningli Wang, MD

Director of Beijing Tongren Eye Center